A Phase III, Randomized, Double-blind, Multicenter, Global Study of Rilvegostomig or Pembrolizumab in Combination with Platinum-based Chemotherapy for the Firstline Treatment of Patients with Metastatic Non-squamous Non-small Cell Lung...